9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide

DB02842ExperimentalSmall molecule

9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA.

Formula / weight: C₁₉H₂₂N₄O · 322.4042 g/mol (avg)

Resolves to

Compound

UNII0LY4HYL6F8ChEMBLCHEMBL287038PubChem150238

Structure

InChIKeyVNWAULKXOPRJEL-UHFFFAOYSA-NSMILESCN(C)CCCNC(=O)C1=CC=CC2=C(N)C3=C(C=CC=C3)N=C12

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of 9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account